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Background: Mortality from non-communicable diseases (NCDs) is a major global issue, as other categories of
mortality have diminished and life expectancy has increased. The World Health Organization’s Member States
have called for a 25% reduction in premature NCD mortality by 2025, which can only be achieved by substantial
reductions in risk factors and improvements in the management of chronic conditions. A high burden of NCD
mortality among much older people, who have survived other hazards, is inevitable. The INDEPTH Network
collects detailed individual data within defined Health and Demographic Surveillance sites. By registering
deaths and carrying out verbal autopsies to determine cause of death across many such sites, using standardised
methods, the Network seeks to generate population-based mortality statistics that are not otherwise available.
Objective: To describe patterns of adult NCD mortality from INDEPTH Network sites across Africa and
Asia, according to the WHO 2012 verbal autopsy (VA) cause categories, with separate consideration of
premature (1564 years) and older (65 years) NCD mortality.
Design: All adult deaths at INDEPTH sites are routinely registered and followed up with VA interviews. For
this study, VA archives were transformed into the WHO 2012 VA standard format and processed using the
InterVA-4 model to assign cause of death. Routine surveillance data also provide person-time denominators
for mortality rates.
Results: A total of 80,726 adult (over 15 years) deaths were documented over 7,423,497 person-years of
observation. NCDs were attributed as the cause for 35.6% of these deaths. Slightly less than half of adult NCD
deaths occurred in the 1564 age group. Detailed results are presented by age and sex for leading causes of NCD
mortality. Per-site rates of NCD mortality were significantly correlated with rates of HIV/AIDS-related mortality.
Conclusions: These findings present important evidence on the distribution of NCD mortality across a
wide range of African and Asian settings. This comes against a background of global concern about the burden
of NCD mortality, especially among adults aged under 70, and provides an important baseline for future work.
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M
ortality due to non-communicable diseases
(NCDs) of various kinds has become an in-
creasing focus of attention in recent years (1),
including at a special meeting of the UN General Assem-
bly in September 2011 (2). This has happened both
because of rapid increases in major NCD risk factors to
which billions of people globally are exposed and also
because many populations are ageing more successfully as
a result of various reductions in early-life mortality and
increases in mid-life survival. Consequently, more people
globally are experiencing the consequences of NCD risk
factors in middle and later life, according to the classic
theories of epidemiological transition (3). In 2012, WHO
Member States at the World Health Assembly made a re-
solution to ‘adopt a global target of a 25% reduction in pre-
mature mortality from non-communicable diseases by 2025’
(4), although this has been widely misquoted with the omis-
sion of the word ‘premature’. The biological reality is that
human beings who survive into their 80s and 90s, thereby
having avoided death from many other causes, are extremely
likely to die of NCDs. The public health imperatives around
NCDs therefore relate to preventing or delaying NCD in-
cidence (including risk factor management) and effectively
managing chronic conditions in the decades of mid-life.
INDEPTH Network
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There has been much written about epidemics of NCD
morbidity and mortality globally, and particularly in low-
and middle-income countries (5). While it is certainly
true that there are many more NCD deaths now than
there have been previously, it is critical to understand
the medical, social, and demographic drivers of these
changes, in addition to trends in specific risk factors,
diseases, and health systems responses. This is important
in terms of positioning the burden of NCDs appropri-
ately in future development agendas (6).
The INDEPTH Network works with Health and Demo-
graphic Surveillance sites (HDSS) across Africa and Asia,
which each follow circumscribed populations on a long-
itudinal basis. Core data collected include person-time at
risk, together with deaths and, by means of verbal autopsy
(VA), assessment of cause of death (7).
Our aim in this paper is to document deaths among
adults (15 years upwards) on the basis of a dataset col-
lected at 22 INDEPTH HDSSs covering Africa and Asia
(8), looking particularly at those deaths attributable to
NCDs. Although these 22 sites are not designed to be
a representative sample, they enable comparisons to be
made over widely differing situations.
Methods
The overall INDEPTH dataset (9) from which these adult
NCD mortality analyses are drawn is described in detail
elsewhere (8). Across the 22 participating sites (1031),
there was documentation on 80,726 deaths in 7,423,497
person-years of observation for people aged 15 and over.
VA interviews were successfully completed on 72,330
(89.6%) of the deaths that occurred. A summary of the
detailed methods used in common for this series of multi-
site papers is shown in Box 1. NCD mortality was defined
as neoplasms, metabolic, cardiovascular, respiratory, abdo-
minal, neurological and other NCDs, corresponding to
chapters in WHO 2012 VA standard.
Box 1. Summary of methodology based on the
detailed description in the introductory paper (8).
Agesextime standardisation
To avoid effects of differences and changes in age
sex structures of populations, mortality fractions
and rates have been adjusted using the INDEPTH
2013 population standard (32). A weighting factor
was calculated for each site, age group, sex, and year
category in relation to the standard for the corre-
sponding age group and sex, and incorporated into
the overall dataset. This is referred to in this paper
as agesex-time standardisation in the contexts
where it is used.
Cause of death assignment
The InterVA-4 (version 4.02) probabilistic model was
used for all the cause of death assignments in the
overall dataset (33). InterVA-4 is fully compliant with
the WHO 2012 VA standard and generates causes of
death categorised by ICD-10 groups (34). The data
reported here were collected before the WHO 2012
VA standard was available, but were transformed
into the WHO 2012 and InterVA-4 format to
optimise cross-site standardisation in cause of death
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Fig. 1. Map showing agesextime standardised proportions of mortality due to non-communicable diseases and agesextime
standardised non-communicable disease mortality rates per 1,000 person-years, for 21 INDEPTH sites.
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attribution. For a small proportion of deaths, VA in-
terviews were not successfully completed; a few others
contained inadequate information to arrive at a cause
of death. InterVA-4 assigns causes of death (maxi-
mum 3) with associated likelihoods; thus, cases for
which likely causes did not total to 100% were also
assigned a residual indeterminate component. This
served as a means of encapsulating uncertainty in
cause of death at the individual level within the overall
dataset, as well as accounting for 100% of every death.
Overall dataset
The overall public-domain dataset (9) thus contains
between one and four records for each death, with
the sum of likelihoods for each individual being
unity. Each record includes a specific cause of death,
its likelihood, and its agesextime weighting.
In this context, all of these data are secondary datasets
derived from primary data collected separately by each
participating site. In all cases, the primary data collection
was covered by site-level ethical approvals relating to on-
going health and demographic surveillance in those
specific locations. No individual identity or household
location data were included in the secondary data and no
specific ethical approvals were required for these pooled
analyses.
Results
After agesextime standardisation, 81814.1 deaths were
documented, of which 73288.7 were covered by VA inter-
views; the InterVA-4 model was unable to assign any
cause of death for 3458.3 deaths (4.2%), and residual
uncertainties (residual likelihoods in cases where likely
cause(s) of death did not total to 100%) accounted for
5864.2 deaths (7.2%). As a consequence of sites returning
data over a range of time periods, 4.6% of the person-
time observed occurred before 2000, 30.0% from 2000 to
2005, and 69.4% from 2006 to 2012.
Non-NCD causes were attributed to 35478.5 deaths
(43.4%), while 28487.7 deaths (34.8%) were attributed to
20 specific WHO 2012 cause of death categories, plus the
residual ‘other and unspecified NCD’ category. Since the
Purworejo, Indonesia, site achieved limited coverage of
adult VAs, and did not report for the period 20062012,
that site is excluded from the following analyses (1173.4
deaths in 185,306 person-years).
Figure 1 maps the 21 INDEPTH sites, showing the age
sextime standardised NCD-specific fraction of adult mor-
tality and the agesextime standardised NCD-specific
mortality rate per 1,000 person-years for each site. This
shows a relatively narrow range of variation across sites,
while the sites with the highest proportions of NCD-
attributable mortality are not necessarily those with the
highest rates. Generally, higher proportions of NCD mor-
tality, but not always higher rates, were found in Asia
compared to Africa. The urban site in Ouagadougou,
Burkina Faso, returned the highest proportion of NCD
mortality in Africa (46.6%), while the Africa Centre,
South Africa, site reported the highest rate of NCD mor-
tality (5.79 per 1,000 person-years). The highest propor-
tion and rate of NCD mortality in Asia was 66.9% and
4.39 per 1,000 person-years, respectively, at the AMK,
Bangladesh, site.
Table 1 shows mortality rates per 1,000 person-years for
NCD causes. Age groupings follow the WHO 2012 cate-
gories (1549, 5064, 65). NCD mortality rates were
substantially lower in the 1549 age group (range 0.31 to
2.76 per 1,000 person-years across all sites and periods)
compared to the 5064 age group (range 2.81 to 14.06 per
1,000 person-years) and more so compared to the 65-plus
age group (range 10.72 to 97.20 per 1,000 person-years).
Figure 2 shows the agesextime standardised mor-
tality rates by site for sub-categories of NCD causes of
death (neoplasms, metabolic, cardiovascular, respiratory,
abdominal, neurological and other NCDs, according
to chapters in WHO 2012 VA standard (34)) for 21
INDEPTH HDSS sites. These categories differ slightly
from the four main NCD groups that are commonly
considered in the global NCD literature, namely cancer,
diabetes, cardiovascular disease, and chronic respiratory
disease. Cancer and cardiovascular disease map directly
to the WHO 2012 VA neoplasms and cardiovascular dis-
ease chapters, respectively. Diabetes accounted for 72%
of deaths in the metabolic disease chapter, and chronic
obstructive pulmonary disease accounted for 65% of
deaths in the chronic respiratory disease chapter.
The population burden of premature NCD mortality
has to be considered in terms of relative numbers of deaths
between age groups, rather than only cause-specific rates,
because of the very different population proportions in
various age groups. While the mortality rate ratios for
NCD mortality between the 1564 and over-65 year
age groups varied from 1:7 (Navrongo, Ghana) to 1:107
(Nairobi, Kenya), with a median of 1:18 (Niakhar,
Senegal), this does not mean that the overwhelming
burden of NCD mortality in terms of numbers of deaths
lay within the over-65 age group. Person-time for the over-
65 age group ranged from 1.4% of that for the 1564 age
group (Nairobi, Kenya) to 13.8% (FilaBavi, Vietnam),
with a median of 8.2% (Chakaria, Bangladesh). NCD
mortality rates for the 1564 year age group ranged from
0.12 per 1,000 person-years in the Matlab, Bangladesh,
site to 0.77 per 1,000 person-years in the Africa Centre,
South Africa, site. Similarly for the over-65 age group,
the range was from 1.24 in FilaBavi, Vietnam, to 13.4
in Nairobi, Kenya. Consequently, the numbers of NCD
deaths in the 1564 age group, which might be considered
as ‘premature’ NCD mortality, were considerable. Figure 3
presents the percentages of adult NCD deaths for the 1564
INDEPTH Network
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Fig. 2. Agesextime standardised mortality rates per 1,000 person-years among adults (15 years and over) in 21 INDEPTH
HDSS sites in Africa and Asia, by sub-category of non-communicable diseases causing death (according to WHO 2012 VA
cause of death chapters).
Table 1. NCD mortality rates per 1,000 person-years by site, age group and period
Age group
1549 years 5064 years 65 years
Period B2000 20002005 20062012 B2000 20002005 20062012 B2000 20002005 20062012
Matlab, Bangladesh 0.81 0.83 6.33 7.41 37.55 41.27
Bandarban, Bangladesh 0.83 4.80 18.31
Chakaria, Bangladesh 0.77 7.09 35.58
AMK, Bangladesh 0.87 0.75 6.60 7.12 45.29 43.82
Nouna, Burkina Faso 0.70 0.48 0.27 7.11 3.64 2.80 23.22 16.81 9.67
Ouagadougou, Burkina Faso 0.63 5.87 21.29
Taabo, Coˆte d’Ivoire 0.67 3.77 16.91
Kilite Awlaelo, Ethiopia 0.49 1.52 12.32
Farafenni, The Gambia 1.07 0.85 0.65 7.61 6.93 4.06 24.57 29.12 21.58
Navrongo, Ghana 1.87 1.72 10.16 8.96 26.82 24.51
Dodowa, Ghana 0.84 5.55 19.07
Ballabgarh, India 0.56 6.00 30.44
Vadu, India 0.43 3.90 17.46
Kilifi, Kenya 0.65 5.45 27.68
Kisumu, Kenya 2.44 1.65 7.96 7.36 25.95 32.05
Nairobi, Kenya 0.45 0.61 4.21 2.76 12.64 19.37
Karonga, Malawi 1.63 0.79 5.70 4.70 27.81 23.31
Niakhar, Senegal 0.76 0.56 3.15 2.54 24.22 16.15
Agincourt, South Africa 0.53 1.02 1.25 4.01 6.88 7.79 17.10 22.48 27.26
Africa Centre, South Africa 1.26 1.06 10.54 10.50 36.86 36.93
FilaBavi, Vietnam 0.96 3.76 28.63
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and over 65-year age groups by site, using the same cause
categories as Fig. 2, to illustrate the magnitude of the bur-
den of premature NCD mortality. The overall bar for each
site represents 100% of NCD deaths, split by cause cate-
gories and age group. Consequently, bars relating to higher
life expectancy countries, with higher proportions of older
people, tend to be shifted further to the right. Slightly
more than half of the overall adult NCD deaths occurred
in the over-65 age group, to the right; deaths shown to the
left of the axis might be considered as ‘premature’. Sites
are shown in decreasing order of overall adult NCD mor-
tality rate, the same as in Fig. 2, for ease of comparison.
Table 2 shows cause-specific rates at each site for the
various categories of neoplasms specified in the WHO
2012 VA standard, separately for the under- and over-65
year age groups, and by sex, for the period 20062012.
Table 3 shows cause-specific rates at each site for other
selected categories of NCDs specified in the WHO 2012
VA standard, separately for the under- and over-65 year
age groups, and by sex, for the period 20062012.
Because some of the sites reporting the highest rates of
NCD mortality were also those with the greatest burden
of HIV/AIDS-related mortality (as explored from the
same dataset in a separate paper (35)), in Fig. 4 we pre-
sent, separately for the 1564 and over-65 year age
groups, the correlations between NCD and HIV/AIDS
mortality rates, showing points for each site and least
absolute deviations regression lines for both age groups.
In both age categories, correlations are significant
(pB0.005; R20.40 and 0.37, respectively) and suggest
that in high HIV settings, around half of the mortality
attributed to NCDs may well be associated with HIV.
This was also reflected in falling NCD mortality rates
among younger adults at most African sites between the
200005 and 200612 periods (Table 1), as HIV/AIDS-
related mortality reduced sharply (35).
Discussion
This study reports NCD mortality patterns for a large
number of adults across a wide range of settings in Africa
and Asia. Being part of the overall INDEPTH cause-
specific mortality study (8), these rates for NCDs cons-
titute a component of complete mortality surveillance in
each site, as distinct from studies only considering NCDs.
The agesextime standardised results presented here
enable comparisons to be made between sites allowing for
the dynamics of agesex population profiles in different
places.
Although proportions of NCD mortality were gener-
ally higher in Asian sites (Fig. 1), rates of NCD mortality
were more consistent across African and Asian sites. This
observation is driven less by NCD-specific factors than
by demographic transition. Many populations in Asia are
experiencing marked increases in mid-life survival, and
Fig. 3. Agesextime standardised percentages of adult NCD deaths for the 1564 and over 65 year age groups by site and
cause category.
INDEPTH Network
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Table 2. Cause-specific adult mortality rates for neoplasms (according to WHO 2012 VA cause categories), by site, age group, and sex for 20062012
Oral neoplasms Digestive neoplasms Respiratory neoplasms
Breast
neoplasms Reproductive neoplasms Other neoplasms
Sex Males Females Males Females Males Females Females Males Females Males Females
Age (years) B65 65 B65 65 B65 65 B65 65 B65 65 B65 65 B65 65 B65 65 B65 65 B65 65 B65 65
Bangladesh: Matlab 0.01 0.01 0.04 0.45 3.84 0.23 2.35 0.38 5.41 0.12 2.80 0.03 0.06 0.03 0.56 0.05 1.34 0.19 1.95 0.05 1.89
Bangladesh: Bandarban 0.02 0.61 0.70 0.19 1.30 0.17 3.88 1.97 0.06 0.04 0.14 1.40 0.24 0.71 0.05 0.77
Bangladesh: Chakaria 0.2 0.16 1.82 0.08 1.38 0.16 4.47 0.15 2.36 0.02 0.37 0.00 0.69 0.02 1.01 0.30 2.55 0.18 1.72
Bangladesh: AMK 0.19 0.01 0.30 2.23 0.25 3.12 0.19 5.40 0.09 1.76 0.02 0.01 0.42 0.04 1.02 0.11 1.46 0.04 1.55
Burkina Faso: Nouna 0.03 0.35 0.01 0.11 0.02 0.00 0.23
Burkina Faso: Ouagadougou 0.01 0.01 0.20 3.85 0.15 0.64 0.19 2.55 0.11 1.69 0.04 0.05 0.76 0.07 0.52 0.08 0.72 0.01 0.31
Cote d’Ivoire: Taabo 0.07 1.55 0.23 1.52 0.05 1.69 0.01 0.37 0.03 0.03 0.14 1.14 0.06 0.08 2.21 1.25
Ethiopia: Kilite Awlaelo 0.04 0.80 0.07 1.27 0.08 1.88 0.05 1.27 0.41 0.03 0.44 0.05 0.87 1.43
The Gambia: Farafenni 0.52 0.32 2.59 0.15 1.52 0.03 1.40 0.03 1.03 0.08 0.02 0.99 0.06 0.14 2.51 0.06 1.84
Ghana: Navrongo 0.04 0.38 0.03 0.09 1.57 9.51 0.89 5.25 0.29 3.78 0.11 1.38 0.14 0.34 0.13 1.08 0.15 1.80 0.05 0.33 0.01 0.29
Ghana: Dodowa 0.03 0.01 0.32 3.37 0.25 1.99 0.02 0.56 0.04 0.53 0.05 0.16 0.02 0.2 0.05 0.48 0.03 1.18 0.05 0.84
India: Ballabgarh 0.01 0.08 0.01 0.26 0.27 2.82 0.19 2.13 0.05 1.16 0.03 0.80 0.12 0.06 2.06 0.03 1.13 0.05 0.31 0.04 0.30
India: Vadu 0.01 0.47 0.27 5.95 0.10 1.17 0.04 1.80 0.05 1.08 0.06 0.02 0.07 0.07 1.43 0.02 0.19
Kenya: Kilifi 0.45 0.01 0.17 2.85 0.12 0.94 0.29 4.02 0.14 2.36 0.01 0.01 1.02 0.05 0.55 0.14 3.16 0.07 1.27
Kenya: Kisumu 0.03 0.06 0.02 0.10 0.39 3.33 0.31 2.01 0.36 5.11 0.27 3.19 0.04 0.07 0.01 0.34 0.08 0.55 0.46 3.47 0.19 3.31
Kenya: Nairobi 0.14 0.01 0.07 0.86 0.02 1.48 0.07 4.41 0.06 2.80 0.01 0.45 0.01 0.04 1.71 0.06 0.84 0.01 0.44
Malawi: Karonga 0.01 0.22 2.56 0.20 1.12 0.25 0.01 0.08 0.03 0.21 0.02 0.55 0.17 1.27 0.02 0.01
Senegal: Niakhar 0.09 0.55 0.07 0.19 0.14 0.06 0.13 0.01 0.24 0.01 0.82 0.25 4.59 0.02 2.02
South Africa: Agincourt 0.01 0.01 0.09 0.24 1.29 0.17 2.69 0.26 2.70 0.19 2.68 0.08 0.13 0.02 0.24 0.15 0.68 0.12 0.99 0.07 1.69
South Africa: Africa Centre 0.03 0.05 0.02 0.07 0.38 1.88 0.18 0.86 0.34 5.42 0.20 1.62 0.06 0.27 0.04 1.31 0.23 1.47 0.18 2.31 0.07 1.03
Vietnam: FilaBavi 0.01 0.24 2.85 0.17 1.37 0.38 8.61 0.06 2.74 0.01 0.03 0.50 0.04 1.06 0.20 3.50 0.08 1.60
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Table 3. Cause-specific adult mortality rates for selected NCDs (according to WHO 2012 VA cause categories), by site, age group, and sex for 20062012
Diabetes mellitus Acute cardiac disease Stroke Other cardiac disease
Chronic obstructive
pulmonary disease
Sex Males Females Males Females Males Females Males Females Males Females
Age (years) B65 65 B65 65 B65 65 B65 65 B65 65 B65 65 B65 65 B65 65 B65 65 B65 65
Bangladesh: Matlab 0.04 0.91 0.03 1.71 0.30 2.07 0.05 0.47 0.60 14.14 0.39 17.03 0.27 4.74 0.10 3.44 0.13 2.92 0.03 1.71
Bangladesh: Bandarban 0.35 3.75 0.33 0.15 3.15 0.16 2.69 0.06 0.35 0.13 0.73 0.71 0.04 2.64
Bangladesh: Chakaria 0.10 5.19 0.19 7.13 0.06 2.98 0.03 1.39 0.27 5.12 0.24 6.00 0.10 3.28 0.10 2.93 0.11 5.04 0.21 4.95
Bangladesh: AMK 0.09 2.61 0.08 2.26 0.40 2.31 0.06 1.55 0.43 14.38 0.31 16.82 0.35 6.98 0.22 5.06 0.09 5.63 0.06 2.65
Burkina Faso: Nouna 0.07 1.76 0.12 2.22 0.10 0.01 0.04 2.26 0.03 0.27 0.08 0.41 0.25 2.06 0.09 1.35
Burkina Faso: Ouagadougou 0.03 0.26 0.03 0.15 2.86 0.05 1.25 0.29 11.66 0.21 6.54 0.06 5.89 0.06 0.22
Cote d’Ivoire: Taabo 0.51 0.07 1.12 0.02 0.03 0.10 2.87 0.09 0.07 5.63 0.11 0.53 0.03 1.49
Ethiopia: Kilite Awlaelo 0.03 0.53 0.03 0.40 0.03 0.49 0.01 0.18 0.06 1.81 0.08 1.18 0.07 1.16 0.06 0.57 0.09 0.41 0.02 0.61
The Gambia: Farafenni 0.27 0.03 0.14 0.34 0.02 0.43 0.10 6.36 0.31 7.12 0.06 1.94 0.05 0.45 0.02 0.92
Ghana: Navrongo 0.08 1.15 0.07 0.66 0.37 2.64 0.09 0.93 0.26 2.60 0.15 1.88 0.16 2.05 0.14 1.41 0.03 0.76 0.02 0.54
Ghana: Dodowa 0.04 0.78 0.01 0.39 0.24 4.30 0.17 2.60 0.27 4.93 0.30 5.09 0.06 1.48 0.09 1.34 0.01 0.10 0.08
India: Ballabgarh 0.05 1.67 0.05 0.81 0.22 4.38 0.20 1.63 0.26 7.78 0.13 5.38 0.12 3.96 0.07 2.12 0.09 8.54 0.09 4.39
India: Vadu 0.01 0.24 0.02 0.08 1.64 0.08 1.02 0.14 4.12 0.18 5.43 0.07 1.41 0.15 1.17 0.01 1.19 0.74
Kenya: Kilifi 0.04 1.91 0.02 0.73 0.03 0.92 0.02 0.29 0.29 7.00 0.24 7.16 0.15 5.94 0.14 3.84 0.05 1.92 0.03 1.25
Kenya: Kisumu 0.05 2.04 0.02 0.56 0.05 0.85 0.03 0.49 0.13 1.27 0.10 2.18 0.39 8.84 0.38 7.97 0.07 1.89 0.03 1.64
Kenya: Nairobi 0.01 0.00 0.44 0.10 1.16 0.04 1.58 0.04 0.50 0.03 1.81 0.27 5.61 0.27 6.25 0.03 1.23 0.00 1.39
Malawi: Karonga 0.02 1.97 0.08 0.58 0.08 1.06 0.83 0.22 6.41 0.23 7.12 0.04 2.80 0.04 2.76 1.47 0.01 1.72
Senegal: Niakhar 0.60 0.38 1.13 0.59 0.14 0.02 0.20 0.09 5.15 0.03 4.03
South Africa: Agincourt 0.14 1.83 0.12 6.57 0.07 0.29 0.04 0.60 0.25 2.53 0.24 11.42 0.17 2.15 0.19 8.77 0.22 1.69 0.11 4.71
South Africa: Africa Centre 0.18 4.22 0.25 4.20 0.12 0.75 0.06 0.34 0.23 6.36 0.26 6.58 0.33 8.82 0.47 9.79 0.06 4.14 0.08 4.09
Vietnam: FilaBavi 0.02 0.36 0.28 0.06 1.40 0.02 0.42 0.23 8.27 0.12 10.04 0.32 5.00 0.14 2.83 0.02 1.11 0.69
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consequently life expectancy, which lead to historically
low levels of crude mortality. Thus, according to UN
Population estimates, many Asian countries currently
record much lower crude mortality rates than their
European and American counterparts, having reduced
infection-related mortality but not having yet accumu-
lated substantial population proportions of older people
(36). As populations gain larger numbers of older people,
there will be increasing numbers of NCD-related deaths,
even if rates remain the same.
Because not all sites operated population surveillance
for the same time period, we have limited evidence on the
time trends in NCD mortality rates (Table 1). However, in
the sites where trends could be seen, there was little clear
evidence of NCD mortality rates increasing over time. As
expected for NCD mortality, rates increased very mark-
edly with age; however, the relatively small population
proportions of people over 65 years in most of these sites
means that the high mortality rates observed in that age
group do not yet translate into large numbers of deaths.
Figure 2 shows that cancers and cardiovascular dis-
eases were the major components of NCD mortality in
almost all sites. Similar proportions of most causes were
seen across most sites; a notable exception was the lack
of cancer-related mortality at the Nouna, Burkina Faso,
site, which is possibly a consequence of items missing
from the VA instrument in use there. Some cancer deaths
at Nouna were probably misclassified into the relatively
high rates of respiratory and abdominal NCDs at that
site. This is an example of some of the difficulties that
may occur as a result of harmonising VA data collected
at many sites, over different time periods, using a variety
of antecedents to the WHO 2012 standard (37). This is
discussed further in the introductory paper (8) but there
are no simple solutions.
Table 2 shows a breakdown of cancer-related mortality
rates. As one of few long-established national cancer
registries in sub-Saharan Africa, the Gambian cancer
registry has reported incidence rates for various cancers
over more than 20 years, partly with the aim of tracking
possible reductions in liver cancer incidence following the
pilot introduction of hepatitis B vaccination in the 1980s
(38). Although incidence and mortality rates are not dir-
ectly comparable, there are similar agesex patterns in the
Gambian incidence rates and the mortality rates reported
here, particularly for several of the West African sites. In
eastern and southern Africa, cancer mortality rates may
also be influenced by high HIV rates (39). Respiratory
cancer mortality as reported here showed higher rates for
men in most sites over both age groups, which probably
reflects gendered norms around smoking as a risk factor.
Appreciable rates of ‘other neoplasms’ were recorded from
many sites, which may partly reflect a lack of specific
information about cancers recalled in VA interviews, or a
lack of specific items in some historic VA instruments.
Table 3 shows, in the same format as Table 2, mortality
rates for diabetes, cardiovascular disease, and chronic
obstructive pulmonary disease. These categories were
major contributors to NCD mortality across many sites,
although the relative magnitude of these categories of
mortality varied between sites. Some sites were using VA
instruments designed before NCDs were considered to
be major causes of death in the populations concerned. It
is likely that the quality of NCD cause assignment
achievable by InterVA-4 will increase as primary VA
data collected according to the complete WHO 2012 VA
specification become more widely available. Nevertheless,
the overall consistency observed across these varied sites
in many respects suggests that historical inter-site varia-
tions did not have a major influence on the overall pattern
of NCD mortality findings.
The importance of separating NCD mortality into
premature and less-avoidable groupings by age is clearly
illustrated in Fig. 3. Due consideration must be given to
both NCD mortality rates as well as numbers of NCD
deaths in considering how disease burdens may be
changing. Here, we have somewhat arbitrarily taken 65
years as the cut-off for considering premature mortality,
because that fitted with the WHO 2012 VA age groups
used in this dataset. In addition, many of the countries
represented here have life expectancies at birth in the
range of 60 to 70 years, and so 65 years may represent a
reasonable dichotomy in terms of ‘prematurity’. In the
global context, 70 years might be a more reasonable
cut-off (40). As yet, none of the countries represented
here has a top-heavy population pyramid, with the
consequence that there is a reasonably even balance in
proportions of NCD deaths occurring before and after 65
years of age, despite high NCD rates among older people.
However, it is to be expected, as time passes, that there
Fig. 4. Agesextime standardised NCD mortality for
1564 and over-65 year age groups in relation to agesex
time standardised HIV/AIDS-related mortality in the same
populations, all per 1,000 person-years.
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will be a gradual rightward shift in the pattern shown in
Fig. 3, unless increased NCD risk factor exposures at
younger ages also increase NCD mortality rates among
the under-65 age group. Nevertheless, the appreciable
number of NCD deaths recorded among the under-65 age
group must also reflect a considerable burden of chronic
disease morbidity in that otherwise productive age group.
To the contrary, modelling results suggest that it could
be possible to achieve significant global reductions in
premature (under-70 years) NCD deaths if relevant risk
factors were appropriately managed (40); however, the
extent to which those risk factors are likely to be effecti-
vely managed in the countries reported here remains an
important question.
The contribution of diabetes to the overall picture of
NCD mortality in these populations was relatively small
compared to cancers and cardiovascular diseases. Whether
this reflects situations where risk factors are not yet
translating into mortality rates, or whether VA methods
led to some misclassification of diabetes mortality into,
for example, cardiovascular deaths is uncertain.
The correlations between HIV-related mortality and
NCD mortality across the whole adult age range, as
shown in Fig. 4, show how important it is to take a holistic
view of cause-specific mortality across entire populations.
The increased NCD mortality rates in higher HIV mor-
tality populations here are consistent with previous work
that analysed causes of death by HIV status (39). This is
clearly an important factor to bear in mind when com-
paring patterns of NCD mortality across sites with
varying HIV epidemiology. The ICD-10 system tries to
classify almost all deaths in HIV-positive people under the
B2 categories related to HIV (41). In reality, however,
particularly if HIV status is not known and for final
illnesses that are not indicative of HIV/AIDS, it is very
likely (by any means of cause of death assignment) that a
proportion of deaths among HIV-positive people will
be attributed to NCDs. This is likely to be an increasing
issue as higher proportions of HIV-positive people receive
effective antiretroviral treatment.
Conclusions
Against a background of considerable concern about the
magnitude of the global NCD mortality burden, these
population-based findings provide useful geographic
examples of the state of adult NCD mortality across a
range of locations in Africa and Asia, standardised for
ease of comparison. The importance of distinguishing
between premature NCD mortality and the inevitably
high rates of NCDs that occur late in life is clear from
these data. These findings also provide a useful baseline
from which to track future trends in NCD mortality,
using the same standardised methods. It is also evident
that, in areas of high HIV endemicity, NCD mortality
rates have to be seen as possibly including some HIV-
related deaths, in cases where no clear evidence of HIV
status was available.
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